Intravescical electromotive drug administration of Epirubicin: An experimental study

L. Carmignani, M. Panizzutti, F. Verweij, F. Rocco, D. Cova, A. Rossignoli, E. Guido, F. Acocella, G. Vanosi, F. Addis

Research output: Contribution to journalArticle

Abstract

Intravescical instillation of Epirubicin after endoscopic resection for bladder tumors has proved its value in several studies, and has become a common practice. EMDA (Electromotive Drug Administration) consists of an active transport of ionic drugs into tissues by electricity. This particular technique of drug delivery through tissues was tested using Epirubicin. The main objectives of this study were: 1) the development of an experimental model to ascertain such a method of uptake; 2) the evaluation of drug concentration within bladder lesions after passive diffusion or EMDA. Six female Landrace pigs of 30 Kg. weight underwent anaesthesia by Isofluoran and Oxygen. A small epicystotomy was made just above the bladder neck. Then a biopsy of the posterior bladder wall was performed and was followed by electrocoagulation. An electrode-containing catheter was inserted through the cystotomy situated so as to lie in the approximate center of the bladder. In Group I (2 pigs) 50 ml of 0.45% saline containing 50 mg of Epirubicin was instilled and left in the bladder 1 hr. In Group II (2 pigs) 50 ml of 0.45% saline and 50 mg Epirubicin was instilled, and an electric current of 20 mA was passed through the electrode after closure of the abdominal wall. The same 20 mA current was applied in both Group III pigs, in which a solution of 100 ml 0.45% saline and 50 mg Epirubicin was instilled. Electricity was applied during a 15 min period in both Group II and III pigs. After 15 minutes the bladders were drained and excised. Tissue samples were taken from both the endoscopic lesion site and from the intact wall. In addition plasma samples were taken during instillation and after 15, 30 and 60 minutes. Epirubicin was shown in a higher concentration in those areas with lesions. It seems not to be the ideal drug for intravescical EMDA.

Original languageEnglish
Pages (from-to)57-59
Number of pages3
JournalActa Urologica Italica
Volume11
Issue number1
Publication statusPublished - 1997

Fingerprint

Epirubicin
Urinary Bladder
Swine
Pharmaceutical Preparations
Electricity
Electrodes
Cystotomy
Drug Evaluation
Electrocoagulation
Active Biological Transport
Abdominal Wall
Urinary Bladder Neoplasms
Theoretical Models
Catheters
Anesthesia
Oxygen
Biopsy
Weights and Measures

Keywords

  • bladder neoplasm
  • electromotive drug administration
  • epirubicin

ASJC Scopus subject areas

  • Urology

Cite this

Carmignani, L., Panizzutti, M., Verweij, F., Rocco, F., Cova, D., Rossignoli, A., ... Addis, F. (1997). Intravescical electromotive drug administration of Epirubicin: An experimental study. Acta Urologica Italica, 11(1), 57-59.

Intravescical electromotive drug administration of Epirubicin : An experimental study. / Carmignani, L.; Panizzutti, M.; Verweij, F.; Rocco, F.; Cova, D.; Rossignoli, A.; Guido, E.; Acocella, F.; Vanosi, G.; Addis, F.

In: Acta Urologica Italica, Vol. 11, No. 1, 1997, p. 57-59.

Research output: Contribution to journalArticle

Carmignani, L, Panizzutti, M, Verweij, F, Rocco, F, Cova, D, Rossignoli, A, Guido, E, Acocella, F, Vanosi, G & Addis, F 1997, 'Intravescical electromotive drug administration of Epirubicin: An experimental study', Acta Urologica Italica, vol. 11, no. 1, pp. 57-59.
Carmignani L, Panizzutti M, Verweij F, Rocco F, Cova D, Rossignoli A et al. Intravescical electromotive drug administration of Epirubicin: An experimental study. Acta Urologica Italica. 1997;11(1):57-59.
Carmignani, L. ; Panizzutti, M. ; Verweij, F. ; Rocco, F. ; Cova, D. ; Rossignoli, A. ; Guido, E. ; Acocella, F. ; Vanosi, G. ; Addis, F. / Intravescical electromotive drug administration of Epirubicin : An experimental study. In: Acta Urologica Italica. 1997 ; Vol. 11, No. 1. pp. 57-59.
@article{d35e08e02cf64f64a0633b2d69f03930,
title = "Intravescical electromotive drug administration of Epirubicin: An experimental study",
abstract = "Intravescical instillation of Epirubicin after endoscopic resection for bladder tumors has proved its value in several studies, and has become a common practice. EMDA (Electromotive Drug Administration) consists of an active transport of ionic drugs into tissues by electricity. This particular technique of drug delivery through tissues was tested using Epirubicin. The main objectives of this study were: 1) the development of an experimental model to ascertain such a method of uptake; 2) the evaluation of drug concentration within bladder lesions after passive diffusion or EMDA. Six female Landrace pigs of 30 Kg. weight underwent anaesthesia by Isofluoran and Oxygen. A small epicystotomy was made just above the bladder neck. Then a biopsy of the posterior bladder wall was performed and was followed by electrocoagulation. An electrode-containing catheter was inserted through the cystotomy situated so as to lie in the approximate center of the bladder. In Group I (2 pigs) 50 ml of 0.45{\%} saline containing 50 mg of Epirubicin was instilled and left in the bladder 1 hr. In Group II (2 pigs) 50 ml of 0.45{\%} saline and 50 mg Epirubicin was instilled, and an electric current of 20 mA was passed through the electrode after closure of the abdominal wall. The same 20 mA current was applied in both Group III pigs, in which a solution of 100 ml 0.45{\%} saline and 50 mg Epirubicin was instilled. Electricity was applied during a 15 min period in both Group II and III pigs. After 15 minutes the bladders were drained and excised. Tissue samples were taken from both the endoscopic lesion site and from the intact wall. In addition plasma samples were taken during instillation and after 15, 30 and 60 minutes. Epirubicin was shown in a higher concentration in those areas with lesions. It seems not to be the ideal drug for intravescical EMDA.",
keywords = "bladder neoplasm, electromotive drug administration, epirubicin",
author = "L. Carmignani and M. Panizzutti and F. Verweij and F. Rocco and D. Cova and A. Rossignoli and E. Guido and F. Acocella and G. Vanosi and F. Addis",
year = "1997",
language = "English",
volume = "11",
pages = "57--59",
journal = "Acta Urologica Italica",
issn = "0394-2511",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Intravescical electromotive drug administration of Epirubicin

T2 - An experimental study

AU - Carmignani, L.

AU - Panizzutti, M.

AU - Verweij, F.

AU - Rocco, F.

AU - Cova, D.

AU - Rossignoli, A.

AU - Guido, E.

AU - Acocella, F.

AU - Vanosi, G.

AU - Addis, F.

PY - 1997

Y1 - 1997

N2 - Intravescical instillation of Epirubicin after endoscopic resection for bladder tumors has proved its value in several studies, and has become a common practice. EMDA (Electromotive Drug Administration) consists of an active transport of ionic drugs into tissues by electricity. This particular technique of drug delivery through tissues was tested using Epirubicin. The main objectives of this study were: 1) the development of an experimental model to ascertain such a method of uptake; 2) the evaluation of drug concentration within bladder lesions after passive diffusion or EMDA. Six female Landrace pigs of 30 Kg. weight underwent anaesthesia by Isofluoran and Oxygen. A small epicystotomy was made just above the bladder neck. Then a biopsy of the posterior bladder wall was performed and was followed by electrocoagulation. An electrode-containing catheter was inserted through the cystotomy situated so as to lie in the approximate center of the bladder. In Group I (2 pigs) 50 ml of 0.45% saline containing 50 mg of Epirubicin was instilled and left in the bladder 1 hr. In Group II (2 pigs) 50 ml of 0.45% saline and 50 mg Epirubicin was instilled, and an electric current of 20 mA was passed through the electrode after closure of the abdominal wall. The same 20 mA current was applied in both Group III pigs, in which a solution of 100 ml 0.45% saline and 50 mg Epirubicin was instilled. Electricity was applied during a 15 min period in both Group II and III pigs. After 15 minutes the bladders were drained and excised. Tissue samples were taken from both the endoscopic lesion site and from the intact wall. In addition plasma samples were taken during instillation and after 15, 30 and 60 minutes. Epirubicin was shown in a higher concentration in those areas with lesions. It seems not to be the ideal drug for intravescical EMDA.

AB - Intravescical instillation of Epirubicin after endoscopic resection for bladder tumors has proved its value in several studies, and has become a common practice. EMDA (Electromotive Drug Administration) consists of an active transport of ionic drugs into tissues by electricity. This particular technique of drug delivery through tissues was tested using Epirubicin. The main objectives of this study were: 1) the development of an experimental model to ascertain such a method of uptake; 2) the evaluation of drug concentration within bladder lesions after passive diffusion or EMDA. Six female Landrace pigs of 30 Kg. weight underwent anaesthesia by Isofluoran and Oxygen. A small epicystotomy was made just above the bladder neck. Then a biopsy of the posterior bladder wall was performed and was followed by electrocoagulation. An electrode-containing catheter was inserted through the cystotomy situated so as to lie in the approximate center of the bladder. In Group I (2 pigs) 50 ml of 0.45% saline containing 50 mg of Epirubicin was instilled and left in the bladder 1 hr. In Group II (2 pigs) 50 ml of 0.45% saline and 50 mg Epirubicin was instilled, and an electric current of 20 mA was passed through the electrode after closure of the abdominal wall. The same 20 mA current was applied in both Group III pigs, in which a solution of 100 ml 0.45% saline and 50 mg Epirubicin was instilled. Electricity was applied during a 15 min period in both Group II and III pigs. After 15 minutes the bladders were drained and excised. Tissue samples were taken from both the endoscopic lesion site and from the intact wall. In addition plasma samples were taken during instillation and after 15, 30 and 60 minutes. Epirubicin was shown in a higher concentration in those areas with lesions. It seems not to be the ideal drug for intravescical EMDA.

KW - bladder neoplasm

KW - electromotive drug administration

KW - epirubicin

UR - http://www.scopus.com/inward/record.url?scp=0030932497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030932497&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030932497

VL - 11

SP - 57

EP - 59

JO - Acta Urologica Italica

JF - Acta Urologica Italica

SN - 0394-2511

IS - 1

ER -